HISPPD2A inhibitors represent a class of compounds that specifically target the activity of the HISPPD2A enzyme, an important phosphatase involved in the regulation of intracellular signaling pathways. The enzyme itself is known to dephosphorylate a variety of proteins, primarily within the context of cellular signaling cascades that manage crucial cellular processes such as growth, differentiation, and apoptosis. Inhibition of HISPPD2A alters these pathways by preventing the removal of phosphate groups from target proteins, which can modulate their activation state and downstream effects. This dynamic plays a critical role in maintaining the balance of cellular responses to external stimuli, as phosphorylation states are key regulators of protein activity.
On a molecular level, HISPPD2A inhibitors are typically designed to interfere with the enzyme's active site, where they either competitively or non-competitively bind to prevent substrate access. These inhibitors may be small organic molecules or larger peptides, depending on the specific structure of the inhibitor and its binding affinity. Inhibition of HISPPD2A can lead to prolonged activation or inactivation of its substrate proteins, thus impacting a range of signal transduction processes. The chemical interactions involved in HISPPD2A inhibition include hydrogen bonding, hydrophobic interactions, and in some cases, covalent modifications. The structural diversity of HISPPD2A inhibitors reflects the complexity of designing molecules that can selectively and efficiently inhibit this enzyme, given its role in multiple cellular pathways and its interaction with a broad spectrum of substrates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Inhibits ribonucleotide reductase, impacting DNA synthesis, and may indirectly affect HISPPD2A. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $36.00 $107.00 | 1 | |
Inhibits inosine monophosphate dehydrogenase, affecting purine synthesis, potentially impacting HISPPD2A. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $62.00 $108.00 $210.00 | 1 | |
An antiviral drug that interferes with nucleotide synthesis, possibly affecting HISPPD2A. | ||||||
6-Mercaptopurine | 50-44-2 | sc-361087 sc-361087A | 50 mg 100 mg | $71.00 $102.00 | ||
A purine antimetabolite influencing purine metabolism, potentially affecting HISPPD2A. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $41.00 $53.00 | 3 | |
Affects purine metabolism as a purine antimetabolite, potentially impacting HISPPD2A. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $57.00 $200.00 | 15 | |
A nucleotide analog used in chemotherapy, potentially influencing HISPPD2A. | ||||||
2-Chloro-2′-deoxyadenosine | 4291-63-8 | sc-202399 | 10 mg | $144.00 | 1 | |
A purine nucleoside analog affecting DNA synthesis and repair, potentially impacting HISPPD2A activity. | ||||||
Capecitabine | 154361-50-9 | sc-205618 sc-205618A sc-205618B | 250 mg 1 g 5 g | $63.00 $204.00 $316.00 | 16 | |
A prodrug of 5-FU that interferes with DNA synthesis, possibly affecting HISPPD2A. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $147.00 $258.00 $508.00 $717.00 $1432.00 | 1 | |
A nucleoside analog used in chemotherapy, potentially influencing HISPPD2A. | ||||||